Class 1 integrons in ciprofloxacin-resistant Escherichia coli strains from two Dutch hospitals

Clinical Microbiology and Infection

Volumn 11, Issue 11, 2005, Pages 898-902

  Mooij, M J ^a   Schouten, I ^a   Vos, G ^b   Van Belkum, A ^b   Vandenbroucke Grauls, C M J E ^a,c   Savelkoul, P H M ^a   Schultsz, C ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Ciprofloxacin; Escherichia coli; Integrons; Quinolone resistance; Resistance

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; DNA; DNA TOPOISOMERASE (ATP HYDROLYSING) A; GENTAMICIN; INTEGRASE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TOBRAMYCIN;

AMPLIFIED FRAGMENT LENGTH POLYMORPHISM; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATION; DNA DETERMINATION; DNA FINGERPRINTING; ESCHERICHIA COLI; GENE MUTATION; GRAM NEGATIVE INFECTION; GYRA GENE; HUMAN; INTEGRON; INTI1 GENE; NETHERLANDS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; QNRA GENE; UNIVERSITY HOSPITAL;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; NEGIBACTERIA;

EID: 27544458746     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2005.01259.x     Document Type: Article

References (27)

1. Leverstein-van Hall MA, Paauw A, Box ATA, Blok HEM, Verhoef J, Fluit AC. Presence of integron-associated resistance in the community is widespread and contributes to multidrug resistance in the hospital. J Clin Microbiol 2002; 40: 3038-3040.
2. Leverstein-van Hall MA, Box AT, Blok HE, Paauw A, Fluit AC, Verhoef J. Evidence of extensive interspecies transfer of integron-mediated antimicrobial resistance genes among multidrug-resistant Enterobacteriaceae in a clinical setting. J Infect Dis 2002; 186: 49-56.
3. Leverstein-van Hall MA, Blok HE, Donders RT, Paauw A, Fluit AC, Verhoef J. Multidrug resistance among Enterobacteriaceae is strongly associated with the presence of integrons and is independent of species or isolate origin. J Infect Dis 2003; 187: 251-259.
4. Martinez-Freijo P, Fluit AC, Schmitz FJ, Grek VS, Verhoef J, Jones ME. Class I integrons in Gram-negative isolates from different European hospitals and association with decreased susceptibility to multiple antibiotic compounds. J Antimicrob Chemother 1998; 42: 689-696.
5. Schmitz FJ, Hafner D, Geisel R et al. Increased prevalence of class I integrons in Escherichia coli, Klebsiella species, and Enterobacter species isolates over a 7-year period in a German university hospital. J Clin Microbiol 2001; 39: 3724-3726.
6. Van Belkum A, Goessens W, van der Schee C et al. Rapid emergence of ciprofloxacin-resistant Enterobacteriaceae containing multiple gentamicin resistance-associated integrons in a Dutch hospital. Emerg Infect Dis 2001; 7: 862-871.
7. Martinez-Martinez L, Pascual A, Jacoby GA. Quinolone resistance from a transferable plasmid. Lancet 1998; 351: 797-799.
8. Jacoby GA, Chow N, Waites KB. Prevalence of plasmid-mediated quinolone resistance. Antimicrob Agents Chemother 2003; 47: 559-562.
9. Tran JH, Jacoby GA. Mechanism of plasmid-mediated quinolone resistance. Proc Natl Acad Sci USA 2002; 99: 5638-5642.
10. Wang M, Tran JH, Jacoby GA, Zhang Y, Wang F, Hooper DC. Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai, China. Antimicrob Agents Chemother 2003; 47: 2242-2248.
11. Wang M, Sahm DF, Jacoby GA, Zhang Y, Hooper DC. Activities of newer quinolones against Escherichia coli and Klebsiella pneumoniae containing the plasmid-mediated quinolone resistance determinant qnr. Antimicrob Agents Chemother 2004; 48: 1400-1401.
12. Mammeri H, Van De Loo M, Poirel L, Martinez-Martinez L, Nordmann P. Emergence of plasmid-mediated quinolone resistance in Escherichia coli in Europe. Antimicrob Agents Chemother 2005; 49: 71-76.
13. Jonas D, Biehler K, Hartung D, Spitzmuller B, Daschner FD. Plasmid-mediated quinolone resistance in isolates obtained in German intensive care units. Antimicrob Agents Chemother 2005; 49: 773-775.
14. Hata M, Suzuki M, Matsumoto M et al. Cloning of a novel gene for quinolone resistance from a transferable plasmid in Shigella flexneri 2b. Antimicrob Agents Chemother 2005; 49: 801-803.
15. Higgins PG, Fluit AC, Schmitz FJ. Fluoroquinolones: structure and target sites. Curr Drug Targets 2003; 4: 181-190.
16. Poole K. Efflux-mediated resistance to fluoroquinolones in Gram-negative bacteria. Antimicrob Agents Chemother 2000; 44: 2233-2241.
17. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests, 8th edn. Approved standard M2-A8. Wayne, PA: NCCLS, 2003.
18. Savelkoul PHM, Aarts HJM, de Haas J et al. Amplified-fragment length polymorphism analysis: the state of an art. J Clin Microbiol 1999; 37: 3083-3091.
19. Vos P, Hogers R, Bleeker M et al. AFLP: a new technique for DNA fingerprinting. Nucleic Acids Res 1995; 23: 4407-4414.
20. Koeleman JG, Stoof J, Van Der Bijl MW, Vandenbroucke-Grauls CM, Savelkoul PH. Identification of epidemic strains of Acinetobacter baumannii by integrase gene PCR. J Clin Microbiol 2001; 39: 8-13.
21. Levesque C, Piche L, Larose C, Roy PH. PCR mapping of integrons reveals several novel combinations of resistance genes. Antimicrob Agents Chemother 1995; 39: 185-191.
22. Blattner FR, Plunkett G III, Bloch CA et al. The complete genome sequence of Escherichia coli K-12. Science 1997; 277: 1453-1474.
23. Johnson JR, Manges AR, O'Bryan TT, Riley LW. A disseminated multidrug-resistant clonal group of uropathogenic Escherichia coli in pyelonephritis. Lancet 2002; 359: 2249-2251.
24. Manges AR, Johnson JR, Foxman B, O'Bryan TT, Fullerton KE, Riley LW. Widespread distribution of urinary tract infections caused by a multidrug-resistant Escherichia coli clonal group. N Engl J Med 2001; 345: 1007-1013.
25. Manges AR, Dietrich PS, Riley LW. Multidrug-resistant Escherichia coli clonal groups causing community-acquired pyelonephritis. Clin Infect Dis 2004; 38: 329-334.
26. Poirel L, Guibert M, Bellais S, Naas T, Nordmann P. Integron- and carbenicillinase-mediated reduced susceptibility to amoxicillin-clavulanic acid in isolates of multidrug-resistant Salmonella enterica serotype typhimurium DT104 from French patients. Antimicrob Agents Chemother 1999; 43: 1098-1104.
27. Hooper DC. Mechanisms of fluoroquinolone resistance. Drug Resist Updates 1999; 2: 38-55.